BRANDX defines a
new standard of care
icon-mail Learn about testing
gotoMail
icon-dosing See the Dosing Guide
gotoDosing
icon-graph Review the guidelines
gotoGraph
Important Safety Information
  • There are no contraindications for BRANDX.
  • The most common adverse reactions (≥20%) were nausea, fatigue, and decreased appetite.
  • 5% of patients discontinued treatment after 4 months of use.
  • The long term safety and efficacy (>1 year) were assessed in 2 multinational trials.

Please see the full Prescribing information for important dose modification information regarding BRANDX.

Connect with us

message-icon
close
rep-img icon-msg

Connect with
your local rep
Mon-Fri, 8:00AM-6:00PM Connect now or
schedule a call
connect